NJU Physicians Selected as SJ Mag 2020 Top Docs

From sjmagazine.net: “At a time when South Jersey needed medical professionals the most, they showed up. That’s what superheroes do. They do what’s right, and they help people. Because of that, this year’s Top Docs list has taken on new meaning.”

Congratulations to our New Jersey Urology physicians for their selection as Top Doctors in the September 2020 issue of SJ Magazine! Learn more about each ‘top doc’ by clicking on their name below:

Read the complete list here >

Dr. Sanjay Kasturi Designated as Urolift® Center of Excellence

We’re proud to announce that the New Jersey Urology office of Dr. Sanjay Kasturi in Vineland, NJ, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Kasturi has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Sanjay Kasturi as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Public Statement from NJU

Public Statement from New Jersey Urology

26 Jul 2020 News

New Jersey Urology (NJU) is devastated and heartbroken by the tragic incident that occurred at our Mount Laurel office on Friday, July 24, 2020. A patient’s family member​ fatally shot our dear colleague and friend, Stephanie Anne Horton, a patient service representative at the Mount Laurel office, and wounded a waiting patient. The suspect has been charged and is currently in custody.

Stephanie Anne Horton, Beloved friend and colleague“In light of recent events, we have all been going through unspeakable grief and shock in hearing of Stephanie Horton’s passing from this horrific, senseless act of gun violence,” said Scott Ciccarelli, CEO of New Jersey Urology. “We would like to extend our heartfelt condolences and prayers to Stephanie’s family, colleagues and friends. Words can’t express the deep sorrow for the loss of our dear NJU colleague. She will always be remembered fondly as a true friend and loyal employee, and a selfless, courageous hero. Stephanie will leave a special place in our hearts.“

During the shooting, one of our patients was injured from a gunshot wound to her right knee. Her NJU urologist, along with a fellow patient, were at her side until paramedics arrived. She was taken to Cooper University Hospital where she was treated immediately for reconstructive surgery. We are so saddened that she was a victim in this random act of violence, and sincerely hope for her speedy recovery.

This has been such a difficult and traumatic experience, and we can’t put into words how saddened and heartbroken we are feeling right now. We understand that many employees, especially those in the Mount Laurel office, are struggling with the shock and pain from this senseless tragedy. We are providing ongoing grief counseling as needed to provide some comfort and help towards the path of healing.

We have also reached out to patients who were unfortunate witnesses to this heinous and cowardly act of violence. It is our utmost priority that employees and patients feel safe and protected. Additional security presence has been deployed at the Mount Laurel office parking area and building, and we are currently assessing other security measures for all our practices.

In remembrance of Stephanie Horton, we will be lowering flags at all of our NJU facilities (those with flags) at half-staff on Monday, August 3rd.

NJU would like to extend our sincere thanks for the outpouring of support we have received from all of our NJU offices, and many national and local organizations. We are deeply touched by their thoughtfulness and support during this difficult time.

Thank you from NJU:

Advanced Urology Institute
American Urological Association
Chesapeake Urology
City of Hope Surgery
Connecticut Children’s Hospital
Fraternal Order of Police Mt. Laurel Lodge 191
iSalus Healthcare
Jefferson Health
Jersey Urology
LUGPA
Macs Janitorial
Mayo Clinic
Mid Atlantic Stone Center Atlantic Lithotripsy, LLC
Mount Laurel Fire Department
Mount Laurel Police Department
Neotract / Teleflex
North Carolina Cancer Hospital
Phreesia Inc.
Rancocas Anesthesiology
ReclaimAbility Pain Services
Red Lanterns Farms LLC
Specialty Networks (UroGPO)
Street Road Animal Hospital
The Center for Kidney Care
The Stone Center of NJ
United Urology
Virtua Mt. Laurel Family Physicians
Virtua Surgical and Breast Group of Moorestown Virtua
Zamir Equities
ZERO Cancer

____________

Updated August 4, 2020
The GoFundMe page is now closed. For Stephanie Horton created by coworkers on behalf of her family:  https://gf.me/u/yifx5h.

new york magazine best doctors 2020

New York Magazine Names New York Metro Area’s Best Doctors 2020

We are proud to announce that 33 New Jersey Urology physicians have been honored as New York Magazine’s 2020 Best Doctors in Urology.

The New York Metro Area is home to some of the most prominent and sought after physicians in the country. New York Magazine works with Castle Connolly Medical Ltd., a New York City-based research and information company, who selects the top 10 percent of the region’s physicians by conducting a peer-reviewed survey. Licensed physicians vote for the doctors they view as exceptional, and the Castle Connolly physician-led research team tabulates the results and vets the nominee pool, confirming the doctors’ board certifications and licensing, and investigating their disciplinary histories.

Congratulations to our esteemed urologists from our multiple locations right here in New Jersey!

 

2020 NEW YORK MAGAZINE BEST DOCTORS (Full List):

Mutahar Ahmed, MD
Andrew Bernstein, MD
Rahuldev Bhalla, MD
Thomas Christiano, MD
Thomas Chun, MD
Michael Esposito, MD
Mark Fallick, MD
Joshua Fiske, MD
Glen Gejerman, MD
Martin Goldstein, MD
Steven Katz, MD
George Klafter, MD
Vincent Lanteri, MD
Bernard Lehrhoff, MD
Gregory Lovallo, MD
Daniel Lowe, MD
Eric Margolis, MD
Mark Miller, MD
Thomas Mueller, MD
Marcella Nachmann, MD
Adam Perzin, MD
Ravi Rajan, MD
Steven L. Richards, MD
Kenneth Ring, MD
Gene Rosenberg, MD
Hossein Sadeghi-Nejad, MD
Frank Salvatore, MD
Domenico Savatta, MD
Eric Seaman, MD
Andrew Siegel, MD
Robert B. Simon, MD
Alan Strumeyer, MD
Gary Wasserman, MD

 

The complete list of NJU Best Doctors can be viewed here  >

Philadelphia Magazine Top Doctors 2020

NJU Physicians Selected as Philadelphia Magazine 2020 Top Doctors

4 May 2020 News

We’re proud to announce that five New Jersey Urology physicians have been honored as Philadelphia Magazine 2020 Top Doctors in Urology. These physicians were nominated by their peers as the very best in their field, and were carefully screened and vetted for educational and professional experience before being selected.

Philadelphia Magazine 2020 Top Doctors:

View Philadelphia Magazine’s complete list of Top Doctors > https://bit.ly/2xYmooI 

Telemedicine

Introducing Telemedicine Services for Our Patients

We are all living in unprecedented times, and understand why you may have missed or cancelled your scheduled appointment. Please know that it is also extremely important to us that you continue to receive the care you need even during this difficult time.

With this in mind, New Jersey Urology (NJU) has developed a solution that protects both our patients and our staff. As an alternative to an in-person office visit, NJU is now offering telemedicine services effective immediately. Telemedicine can be done through the comfort of your home allowing your physician to provide a “virtual” visit through your phone or computer.

The Centers for Medicare & Medicaid Services have broadened access to Medicare telemedicine services, and major insurance companies have waived referrals and copay fees and obligations. Please check with your insurance provider as it relates to your individual situation.

“New Jersey Urology is excited to offer the convenience of telemedicine services to our patients. We want to empower our patients and give them the tools they need to manage their health amid the fluid situation we are all experiencing with the COVID-19 threat,” said Scott Ciccarelli, CEO of NJ Urology.

What You Need To Know

  • To limit the exposure of COVID-19, the Centers for Medicare & Medicaid Services (CMS) have broadened access to Medicare telemedicine services.

  • Major insurance companies have waived referrals and copay fees and obligations for telemedicine services (co-pay for other services will still apply).

How To Schedule a Virtual Visit

Call to schedule an appointment and inform the doctor’s office that you are interested in scheduling a virtual visit. You will receive email instructions to get set up. It’s that simple!

We will continue to provide best-in-class urologic care for our patients while taking preventative measures to help contain the community spread of this virus. Together, we will get through these challenging times.

Please contact us to learn more about our telehealth services.

Be well and stay safe!


Bergen County Top Docs 2020

Bergen Magazine Names Bergen County’s Top Docs 2020

We are proud to announce that 7 New Jersey Urology physicians have been honored as 2020 Bergen County’s Top Doctors by BERGEN Magazine.

Bergen County is home to some of the most prominent and sought-after physicians in the country. BERGEN magazine commissioned Professional Research Services (PRS) of Troy, Michigan to select the finalists. All final honorees were fact-checked with the State of New Jersey and the New Jersey Division of Consumer Affairs License Verication System.

Congratulations to our esteemed urologists from our Englewood, and Maywood / Teaneck locations!

 

2020 BERGEN COUNTY’S TOP DOCS:

See BERGEN Magazine’s complete list of Urology doctors here >

Dr. Adam Perzin Designated as Urolift® Center of Excellence

18 Feb 2020 News

We’re proud to announce that the New Jersey Urology office of Dr. Adam Perzin in Burlington County has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Perzin has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. Perzin has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at www.UroLift.com.

About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at www.NeoTract.com.

About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

New Jersey Urology Partners with Urology Care Alliance

2 Dec 2019 News

The partnership creates largest urology network in the United States

Bloomfield, NJ: New Jersey Urology (“NJU”), the leading urology service provider in New Jersey, and Urology Management Associates (“UMA”) are pleased to announce a partnership with Urology Care Alliance (“UCA”), effective December 1, 2019.

The partnership creates the largest urology group in the tri-state area, with 155 providers in 60 locations, including six cancer treatment centers. Combined, the organizations will have more robust resources for patients and employees alike and be able to better serve patients in central New Jersey and eastern Pennsylvania. UCA physicians will continue to provide care in their existing offices serving Mercer, Middlesex, Monmouth, and Somerset Counties in New Jersey, and Bucks County in Pennsylvania.

“We are proud to welcome Urology Care Alliance (UCA) to the NJU family,” Scott Ciccarelli, Chief Executive Officer at UMA, said. “Their innovative practices, centralized locations, and best-in-class urology care increases our ability to provide outstanding patient care. With the addition of UCA’s treatment center, NJU now has six state-of-the-art cancer treatment centers across the state. Our rapid growth validates NJU as a leader in comprehensive urologic services that enables outstanding patient outcomes and facilitates practice growth.”

UCA President Dr. Gary Karlin said, “Urology Care Alliance is looking forward to joining New Jersey Urology. This merger will allow us to continue to offer the finest urologic patient care and expand our services in this ever-changing field of urological medicine.”

UCA CEO Alan Plotkin added, “Joining forces with New Jersey Urology is a great opportunity to continue to grow our practice and to remain a strong urologic and cancer treatment presence in central New Jersey and Bucks County, Pennsylvania.”

The Bloom Organization served as buy-side advisor to UMA. Henry Bloom, founder of The Bloom Organization, said, “We are pleased to be able to support the growth of NJU and UMA and look forward to continuing to build the leading platform in the urology industry.”

NJU welcomes the UCA physicians: Saad Antoun, MD; Alex Arnouk, MD; Akwasi Boateng, MD; Phillip Brackin Jr., MD; Doh Cha, MD; Michael Cohen, MD; William Ding, MD; Jarad Fingerman, DO; Marc Feder, MD; Russell Freid, MD; Drew Hecht, DO; Gary Karlin, MD; Alex Kirshenbaum, MD; David Koota, MD; Steven Orland, MD; Matthew Pagano, MD; Ravi Rajan, MD; Steven Richards, MD; Emad Rizkala, MD; Christopher Schaefer, DO; Marc Schwarzman, MD; Troy Sukkarieh, MD; Deep Trivedi, MD; John Watson, MD; Akira Yamamoto, MD; Vitaly Zholudev, MD.


About Urology Management Associates:

Urology Management Associates was formed in August 2018 to provide administrative services to New Jersey Urology. The establishment of UMA enables NJU to continue to focus on providing world-class urology services while remaining a physician-led organization. UMA plans to partner with additional urology groups to provide administrative practice management services initially in the greater New York metropolitan area with long-term plans to expand nationally.

About The Bloom Organization:

Bloom has been advising physicians on transactions since 1990. Founded and lead by Mr. Henry Bloom, the Company is based in Aventura, FL and serves clients nationwide. Bloom’s investment banking expertise is in the healthcare services sector.

NJ Monthly Top Doctors 2019

NJU Physicians Selected as New Jersey Monthly 2019 Top Doctors

We’re proud to announce that 12 New Jersey Urology physicians have been honored as 2019 Jersey Choice Top Doctors by New Jersey Monthly Magazine.

More than 25,000 New Jersey–based doctors were invited to recommend the physicians they would choose to treat their own family members.

2019 Jersey Choice Top Doctors in Urology:

See New Jersey Monthly’s complete list here >

1 2 3 4

Search

+
Skip to content